UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018594
Receipt number R000021031
Scientific Title Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear Cells
Date of disclosure of the study information 2015/08/07
Last modified on 2016/03/23 19:23:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear Cells

Acronym

Clinical Study of Therapeutic Angiogenesis Using Hypoxic preconditioned PBMNCs

Scientific Title

Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear Cells

Scientific Title:Acronym

Clinical Study of Therapeutic Angiogenesis Using Hypoxic preconditioned PBMNCs

Region

Japan


Condition

Condition

Peripheral arterial occlusive disease

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety of cell therapy for ischemic lower limb with hypoxic preconditioned peripheral blood mononuclear cells

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

The incidence and severity of the adverse events

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Implantation of PBMNCs collected from peripheral blood and cultured under hypoxia for 24 h.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with age 20 to 85 years.
2. Patients with Fontaine class III-IV symptoms.
3. Patients with not expected further improvement with recomended therapy.
4. Patients not adequate for conventional operative therapy.
5. Patients can provide written informed consent for study participation.

Key exclusion criteria

1. Patients suffering from bacterial infections such as treponema palladium, chlamydia, gonorrhea and tuberculosis.
2. Patients suffering from infections such as hepatitis B and C viruses, human immunodeficiency virus, human T lymphotropic virus type 1 and parvovirus B19.
3. Patients with sepsis or suspected with.
4. Patients with malignant neoplasm or history of malignant neoplasm treatmented within five years.
5. Patients with serious endocrine disorders such as uncontrolled thyroid disfunction.
6. Patients with blood disorders except for chronic kidney disease.
7. Patients with liver disease with Child-Pugh classification B or more.
8. Patients with transmissible spongiform encephalopathy or suspected with.
9. Patients with dementia with a a revised version Hasegawa dementia scale score smaller than 4.
10. Patient determined to be ineligible for this clinical study by research attending physician.

Target sample size

7


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kimikazu Hamano

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Surgery and Clinical Science

Zip code


Address

Minamikogushi1-1-1, Ube, Yamaguchi, Japan

TEL

0836-22-2261

Email

kimikazu@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Samura

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Surgery and Clinical Science

Zip code


Address

Minamikogushi1-1-1, Ube, Yamaguchi, Japan

TEL

0836-22-2261

Homepage URL


Email

m.samura@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University Graduate School of Medicine
Department of Surgery and Clinical Science

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University Graduate School of Medicine
Department of Surgery and Clinical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 04 Month 22 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 07 Day

Last modified on

2016 Year 03 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021031


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name